1. Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
- Author
-
George Athanasios Karpouzas, Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, Anne Grete Semb, Joseph Sexton, Patrick Durez, Maria G Tektonidou, Michal Tomčík, Dionicio Angel Galarza-Delgado, Ian Graham, Miguel A González-Gay, Solbritt Rantapää-Dahlqvist, Erkin M Mirrakhimov, Petros P Sfikakis, Virginia Pascual-Ramos, Carol Hitchon, Maria Simona Stoenoiu, Elena Myasoedova, Durga Prasanna Misra, Vikas Agarwal, Dimitrios Vassilopoulos, Piet van Riel, Bindee Kuriya, George Kitas, Rong Mu, Anne M Kerola, Karen Douglas, Andrew A Borg, Pompilio Faggiano, Cindy Crowson, Argyro Lazarini, Diane Gheta, Svetlana Myasoedova, Lev Krougly, Tatiana Valentinovna Popkova, Alena Tuchyňová, Michal Vrablik, Pavel Horak, and Helena Kaspar Medkova
- Subjects
Medicine - Abstract
Aim The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipid and blood pressure (BP) goal attainment in RA-DM and RAwoDM in primary and secondary prevention.Methods The cohort was derived from the Survey of Cardiovascular Disease Risk Factors in Patients with Rheumatoid Arthritis from 53 centres/19 countries/3 continents during 2014–2019. We evaluated the prevalence of cardiovascular disease (CVD) among RA-DM and RAwoDM. The study population was divided into those with and without ASCVD, and within these groups we compared risk factors and CVD preventive treatment between RA-DM and RAwoDM.Results The study population comprised of 10 543 patients with RA, of whom 1381 (13%) had DM. ASCVD was present in 26.7% in RA-DM compared with 11.6% RAwoDM (p
- Published
- 2021
- Full Text
- View/download PDF